KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cardlytics (CDLX) Return on Equity (2017 - 2025)

Cardlytics (CDLX) has disclosed Return on Equity for 9 consecutive years, with 18.46% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity rose 2117.0% year-over-year to 18.46%, compared with a TTM value of 18.46% through Dec 2025, up 2117.0%, and an annual FY2025 reading of 3.26%, down 141.0% over the prior year.
  • Return on Equity was 18.46% for Q4 2025 at Cardlytics, up from 4.1% in the prior quarter.
  • Across five years, Return on Equity topped out at 18.46% in Q4 2025 and bottomed at 4.1% in Q3 2025.
  • Average Return on Equity over 5 years is 0.32%, with a median of 0.89% recorded in 2024.
  • Peak annual rise in Return on Equity hit 2117bps in 2025, while the deepest fall reached -224bps in 2025.
  • Year by year, Return on Equity stood at 0.19% in 2021, then crashed by -530bps to 1.17% in 2022, then skyrocketed by 36bps to 0.75% in 2023, then tumbled by -262bps to 2.71% in 2024, then soared by 781bps to 18.46% in 2025.
  • Business Quant data shows Return on Equity for CDLX at 18.46% in Q4 2025, 4.1% in Q3 2025, and 2.99% in Q2 2025.